There may be a bit of over analysis going on here.
The stock should never have got to the valuation it did, but in hindsight the same could be said for the likes of TPW and ABY. Both good businesses but limited in scope to their home market.
And look at KGN. The founders were gamed by the market and sold stock at $6.40 in 2018, two years later they're $25 and now they're $5.11 ! Parallels with CTT perhaps ?
None of this tells me where the bottom is, but the valuation has become quite reasonable for a company growing so fast.
- Forums
- ASX - By Stock
- CTT
- Pick The Bottom
Pick The Bottom, page-126
Featured News
Add CTT (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.59 |
Change
0.110(7.46%) |
Mkt cap ! $604.2M |
Open | High | Low | Value | Volume |
$1.49 | $1.62 | $1.49 | $4.272M | 2.726M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28651 | $1.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 12487 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28651 | 1.585 |
9 | 66285 | 1.580 |
2 | 9050 | 1.575 |
1 | 10000 | 1.570 |
2 | 8196 | 1.565 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 12487 | 2 |
1.605 | 18608 | 2 |
1.615 | 1000 | 1 |
1.620 | 1000 | 1 |
1.625 | 10600 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
CTT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online